Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Human papillomavirus (HPV)

View all HPV Plague Tetanus
Anthrax Influenza Pneumococcal Typhoid
Diphtheria Japanese encephalitis Polio Varicella (chickenpox)
General Recommendations Measles Rabies Yellow fever
Hib Meningococcal Rotavirus Zoster (shingles)
Hepatitis A Mumps Rubella  
Hepatitis B Pertussis Smallpox  
 

Recommendations - Human papillomavirus (HPV)

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, March 27, 2015; 64(11):300-304
HTML  |  PDF
 
Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, August 29, 2014; 63(RR-5):1-30
HTML  |  PDF
 
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
 
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 28, 2010; 59(20):626-629
HTML  |  PDF
 
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
Source: MMWR, May 28, 2010; 59(20):630-632
HTML  |  PDF
 
Quadrivalent Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24
 
HTML  |  PDF
 
This page was updated on July 16, 2016.
This page was reviewed on July 16, 2016.
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000589) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.